How Long Can Allergan Keep Valeant’s Bid at Bay?

May 12 (Bloomberg) -- Bloomberg’s Drew Armstrong examines Allergan’s rejection of Valeant’s unsolicited offer and actions by the drug maker to find a different buyer other than Valeant. He speaks on Bloomberg Television’s “Market Makers.”
Twitter's CEO Search: Who Are the Leading Candidates?
23:14 - Spark Capital's Nabeel Hyatt, IDC's Crawford Del Prete and Bloomberg's Sarah Frier discuss Twitter's CEO search with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Will FED "Jell" on September Liftoff?
  • Stocks Rebound: What to Expect for the Rest of the Year
  • Investor Sees 'Smile' for Economy in Dental Visits